LMR Partners’s Tenet Healthcare THC Stock Holding History

LMR Partners’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,100	Closed	-$4.89M	–	1731
2025 Q3	$4.89M	Hold	24,100	–	–	0.02%	518
2025 Q2	$4.24M	Buy	+24,100	New	+$3.63M	0.03%	493

Other funds holding THC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LMR Partners's THC Position: Q1 2026 in Review

LMR Partners sold out of Tenet Healthcare (THC) in Q1 2026, closing a stake of 13,377 shares — an estimated $2.66M sold.

LMR Partners first reported a position in THC in Q2 2014 and held it in 22 quarters. The position peaked at $4.66M in Q2 2024. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

LMR Partners reported no remaining Tenet Healthcare position as of Q1 2026 after selling out during the quarter.
LMR Partners sold 13,377 Tenet Healthcare shares in Q1 2026, an estimated $2.66M.
LMR Partners first reported a position in Tenet Healthcare in Q2 2014 and held it in 22 quarters.
LMR Partners's Tenet Healthcare position peaked at $4.66M in Q2 2024.
690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.